These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23356288)

  • 1. Atypical chemokine receptors: from silence to sound.
    Cancellieri C; Vacchini A; Locati M; Bonecchi R; Borroni EM
    Biochem Soc Trans; 2013 Feb; 41(1):231-6. PubMed ID: 23356288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6.
    Borroni EM; Cancellieri C; Vacchini A; Benureau Y; Lagane B; Bachelerie F; Arenzana-Seisdedos F; Mizuno K; Mantovani A; Bonecchi R; Locati M
    Sci Signal; 2013 Apr; 6(273):ra30.1-11, S1-3. PubMed ID: 23633677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying beta-arrestin-dependent chemotaxis and actin-cytoskeletal reorganization.
    McGovern KW; DeFea KA
    Handb Exp Pharmacol; 2014; 219():341-59. PubMed ID: 24292838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of G Protein and β-Arrestin Activation in Chemokine Receptors Signaling.
    Vacchini A; Busnelli M; Chini B; Locati M; Borroni EM
    Methods Enzymol; 2016; 570():421-40. PubMed ID: 26921957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemistry and biology of the atypical chemokine receptors.
    Graham GJ; Locati M; Mantovani A; Rot A; Thelen M
    Immunol Lett; 2012 Jul; 145(1-2):30-8. PubMed ID: 22698181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine decoy receptors: structure-function and biological properties.
    Bonecchi R; Savino B; Borroni EM; Mantovani A; Locati M
    Curr Top Microbiol Immunol; 2010; 341():15-36. PubMed ID: 20373092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of angiotensin II type 1 receptor functional selectivity.
    Aplin M; Bonde MM; Hansen JL
    J Mol Cell Cardiol; 2009 Jan; 46(1):15-24. PubMed ID: 18848837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Violin JD; Lefkowitz RJ
    Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.
    Magnan R; Escrieut C; Gigoux V; De K; Clerc P; Niu F; Azema J; Masri B; Cordomi A; Baltas M; Tikhonova IG; Fourmy D
    J Am Chem Soc; 2013 Feb; 135(7):2560-73. PubMed ID: 23323542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.
    Jorgensen R; Martini L; Schwartz TW; Elling CE
    Mol Endocrinol; 2005 Mar; 19(3):812-23. PubMed ID: 15528268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy Transfer.
    Bonneterre J; Montpas N; Boularan C; Galés C; Heveker N
    Methods Enzymol; 2016; 570():131-53. PubMed ID: 26921945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors.
    Verkaar F; van Rosmalen JW; Blomenröhr M; van Koppen CJ; Blankesteijn WM; Smits JF; Zaman GJ
    Biotechnol Annu Rev; 2008; 14():253-74. PubMed ID: 18606367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCMV-encoded chemokine receptor US28 employs multiple routes for internalization.
    Droese J; Mokros T; Hermosilla R; Schülein R; Lipp M; Höpken UE; Rehm A
    Biochem Biophys Res Commun; 2004 Sep; 322(1):42-9. PubMed ID: 15313171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization.
    Berchiche YA; Gravel S; Pelletier ME; St-Onge G; Heveker N
    Mol Pharmacol; 2011 Mar; 79(3):488-98. PubMed ID: 21088225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis.
    Lagane B; Ballet S; Planchenault T; Balabanian K; Le Poul E; Blanpain C; Percherancier Y; Staropoli I; Vassart G; Oppermann M; Parmentier M; Bachelerie F
    Mol Pharmacol; 2005 Jun; 67(6):1966-76. PubMed ID: 15761117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural snapshot of a β-arrestin-biased receptor.
    Sarma P; Banerjee R; Shukla AK
    Trends Pharmacol Sci; 2023 Jan; 44(1):1-3. PubMed ID: 36057461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-arrestin 2 modulates the activity of nuclear receptor RAR beta2 through activation of ERK2 kinase.
    Piu F; Gauthier NK; Wang F
    Oncogene; 2006 Jan; 25(2):218-29. PubMed ID: 16170358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insight into the binding complex: β-arrestin/CCR5 complex.
    Stambouli N; Dridi M; Wei NN; Jlizi A; Bouraoui A; Elgaaied AB
    J Biomol Struct Dyn; 2014; 32(6):866-75. PubMed ID: 24404772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
    Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction.
    Berglund MM; Schober DA; Statnick MA; McDonald PH; Gehlert DR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):147-56. PubMed ID: 12665544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.